Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project

• Главные авторы: Giorgia Teresa Maniscalco (Автор), Vincenzo Brescia Morra (Автор), Ciro Florio (Автор), Giacomo Lus (Автор), Gioacchino Tedeschi (Автор), Maddalena Cianfrani (Автор), Renato Docimo (Автор), Stefania Miniello (Автор), Felice Romano (Автор), Leonardo Sinisi (Автор), Daniele L. A. Spitaleri (Автор), Giuseppe Longo (Автор), Ugo Trama (Автор), Maria Triassi (Автор), FASM Group (Автор), Cristina Scavone (Автор), Annalisa Capuano (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2020-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background and aim: Disease-modifying therapies (DMTs) used in multiple sclerosis (MS) have distinct safety profiles. In this paper, we report preliminary results of an on-going pharmacovigilance project (the FASM study). Results: Neurologists working at involved multiple sclerosis centers collected...